Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. (NYSE: IFF) is a global leader in sensory experiences and specialty ingredients, serving industries from food technology to pharmaceutical solutions. This dedicated news hub provides investors and industry professionals with essential updates on IFF developments, including earnings reports, strategic partnerships, and scientific breakthroughs.
Key resources include: Quarterly financial results, innovation announcements in flavors/fragrances, bioscience advancements, and sustainability initiatives. Our curated collection ensures access to verified press releases and market analyses that impact IFF's position in the $120B+ specialty chemicals sector.
Bookmark this page for real-time updates on IFF's product launches, regulatory milestones, and leadership changes. Combine technical insights with strategic context to make informed decisions about this NYSE-listed innovator.
IFF (NYSE: IFF) opened a nature-based green hydrogen production facility at its Benicarló, Spain fragrance ingredients plant on November 6, 2025.
The site, in a 10-year renewable hydrogen agreement with Iberdrola, can produce 100 tons of green hydrogen annually, store it on-site with an integrated compressor, and supply hydrogenation for more than 50 key ingredients. IFF says the switch to green hydrogen will eliminate 2,000 tons of CO2e per year and supports its targets of -50% scope 1 & 2 and -30% scope 3 emissions by 2030 and net zero operations by 2040.
IFF (NYSE: IFF) announced that its Board of Directors declared a regular quarterly cash dividend of $0.40 per share. The dividend is payable on January 9, 2026 to shareholders of record as of December 19, 2025.
The announcement reiterates IFF's ongoing capital return via a regular quarterly dividend and provides contact points for media and investor relations.
IFF (NYSE: IFF) announced the 2025 IFF Science Awards honoring Dr. Carles Lerín and Prof. Jan Maarten van Dijl for contributions to human health, nutrition, microbiome science and antimicrobial research.
Dr. Lerín is recognized for research on childhood and adolescent obesity, maternal and early-life nutrition, microbiome links to metabolic health and betaine’s role in growth. Prof. van Dijl is recognized for advances in molecular bacteriology, microbial protein secretion and novel antimicrobial strategies. The award continues the Danisco Foundation legacy and includes a $35,000 prize, with candidates chosen via a rigorous IFF nomination process.
IFF (NYSE: IFF) appointed Brett Icahn and Richard Mulligan, Ph.D. to its board of directors, effective Oct. 20, 2025. The appointments follow a previously disclosed cooperation agreement with Icahn Capital LP. Icahn replaces Vincent Intrieri and was named to the Board’s Audit Committee and Transaction Committee. Mulligan replaces Margarita Paláu-Hernández and was named to the Board’s Innovation Committee. Management highlighted Icahn’s investment experience and Mulligan’s scientific track record. Intrieri and Paláu-Hernández stepped down on Oct. 20, 2025.
IFF (NYSE: IFF) announced a strategic collaboration with BASF on October 21, 2025 to accelerate IFF’s Designed Enzymatic Biomaterials™ platform and develop next‑generation enzyme and polymer technologies for fabric, dish, personal care and industrial cleaning applications.
The partnership combines IFF’s biotechnology and protein engineering with BASF’s chemical and sustainable‑product expertise to scale biobased polymers and innovative enzyme systems while both companies retain independent operations.
International Flavors & Fragrances (NYSE:IFF) will release Q3 2025 earnings after market close on Tue, Nov 4, 2025.
The company will host a live webcast on Wed, Nov 5, 2025 at 9:00 a.m. ET to review results and outlook; the webcast and slide presentation will be available at ir.iff.com. A recorded replay will be posted for those unable to join live.
Investor and media contacts are listed for follow-up.
NACD appointed Jesús Mantas and Wes Bricker to its board of directors, effective October 10, 2025. Mantas is recently retired as global leader of IBM Consulting Business Transformation Services and serves on the board of Biogen (Nasdaq: BIIB) where he chairs the compensation and management development committee. Bricker is Global Assurance Leader at PwC, a former SEC chief accountant, and leads PwC assurance teams across the network.
The appointments add expertise in digital transformation, innovation, assurance, governance, and capital markets to NACD as it advises corporate directors on evolving boardroom challenges.
National Association of Corporate Directors (BIIB) announced that Jesús Mantas and Wes Bricker joined the NACD board of directors effective Oct. 10, 2025. Mantas, recently retired as global leader of IBM Business Transformation Services, serves on the board of Biogen (Nasdaq: BIIB) and chairs its compensation and management development committee. Bricker is Global Assurance Leader at PwC and a former SEC chief accountant, overseeing 134,000 assurance partners and staff across the PwC network. The appointments emphasize expertise in governance, digital transformation, audit, and capital markets.
IFF (NYSE: IFF) announced plans to build a new scent creative center in Mumbai’s Powai neighborhood, expected to be fully operational by first half of 2026. The site expands IFF’s local footprint to 3,650 square meters, more than doubling existing space, and will house more than 100 employees. The modern, technology-enabled facility will include advanced labs, category-spanning evaluation booths, and a state-of-the-art sensory evaluation space to accelerate co-creation, improve speed-to-market, and serve India’s growing fragrance market.
The center aims to blend global expertise with local consumer insight to support product innovation and customer collaboration in Greater Asia.